Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifevantage (LFVN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Lifevantage (LFVN) over the last 16 years, with Q4 2025 value amounting to $35.7 million.

  • Lifevantage's Operating Expenses fell 3014.72% to $35.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $156.4 million, marking a year-over-year decrease of 125.29%. This contributed to the annual value of $171.5 million for FY2025, which is 1105.95% up from last year.
  • As of Q4 2025, Lifevantage's Operating Expenses stood at $35.7 million, which was down 3014.72% from $35.5 million recorded in Q3 2025.
  • Over the past 5 years, Lifevantage's Operating Expenses peaked at $51.1 million during Q4 2024, and registered a low of $35.2 million during Q3 2024.
  • Over the past 5 years, Lifevantage's median Operating Expenses value was $40.5 million (recorded in 2022), while the average stood at $40.1 million.
  • As far as peak fluctuations go, Lifevantage's Operating Expenses soared by 2228.65% in 2024, and later plummeted by 3014.72% in 2025.
  • Over the past 5 years, Lifevantage's Operating Expenses (Quarter) stood at $42.9 million in 2021, then rose by 0.62% to $43.1 million in 2022, then fell by 3.05% to $41.8 million in 2023, then grew by 22.29% to $51.1 million in 2024, then plummeted by 30.15% to $35.7 million in 2025.
  • Its last three reported values are $35.7 million in Q4 2025, $35.5 million for Q3 2025, and $41.9 million during Q2 2025.